BALYO Fundamental Analysis - BALYO SA - PROMESSES

Fundamental Rating

Overall BALYO gets a fundamental rating of 2 out of 10. We evaluated BALYO against 115 industry peers in the Machinery industry. BALYO may be in some trouble as it scores bad on both profitability and health. BALYO is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year BALYO has reported negative net income.
In the past year BALYO has reported a negative cash flow from operations.
In the past 5 years BALYO always reported negative net income.
BALYO had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

With a Return On Assets value of -33.17%, BALYO is not doing good in the industry: 91.30% of the companies in the same industry are doing better.
BALYO has a Return On Equity of -204.95%. This is amonst the worse of the industry: BALYO underperforms 93.04% of its industry peers.

		Industry Rank	Sector Rank
ROA	-33.17%
ROE	-204.95%
ROIC	N/A

ROA(3y)-22.13%

ROA(5y)-19.75%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

BALYO has a worse Gross Margin (34.76%) than 62.61% of its industry peers.
In the last couple of years the Gross Margin of BALYO has grown nicely.
The Profit Margin and Operating Margin are not available for BALYO so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	34.76%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-12.52%

GM growth 5Y37.21%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

BALYO does not have a ROIC to compare to the WACC, probably because it is not profitable.
BALYO has more shares outstanding than it did 1 year ago.
The number of shares outstanding for BALYO has been increased compared to 5 years ago.
Compared to 1 year ago, BALYO has an improved debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of 1.13, we must say that BALYO is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of BALYO (1.13) is worse than 74.78% of its industry peers.
BALYO has a Debt/Equity ratio of 0.82. This is a neutral value indicating BALYO is somewhat dependend on debt financing.
The Debt to Equity ratio of BALYO (0.82) is worse than 71.30% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.82
Debt/FCF	N/A
Altman-Z	1.13

ROIC/WACCN/A

WACC7.76%

2.3 Liquidity

A Current Ratio of 1.35 indicates that BALYO should not have too much problems paying its short term obligations.
The Current ratio of BALYO (1.35) is worse than 61.74% of its industry peers.
BALYO has a Quick Ratio of 1.01. This is a normal value and indicates that BALYO is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.01, BALYO perfoms like the industry average, outperforming 51.30% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	1.35
Quick Ratio	1.01

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 81.03% over the past year.
The Revenue has grown by 11.90% in the past year. This is quite good.
BALYO shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.34% yearly.

EPS 1Y (TTM)81.03%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%73.68%

Revenue 1Y (TTM)11.9%

Revenue growth 3Y10.17%

Revenue growth 5Y7.34%

Sales Q2Q%-3.66%

3.2 Future

Based on estimates for the next years, BALYO will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.47% on average per year.
The Revenue is expected to grow by 4.08% on average over the next years.

EPS Next Y9.52%

EPS Next 2Y15.47%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year-20.83%

Revenue Next 2Y4.08%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BALYO. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BALYO. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as BALYO's earnings are expected to grow with 15.47% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y15.47%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

BALYO does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

BALYO SA - PROMESSES

EPA:BALYO (1/20/2026, 2:15:08 PM)

0.596

0 (-0.33%)

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupCapital Goods

GICS IndustryMachinery

Earnings (Last)10-23 2025-10-23

Earnings (Next)03-18 2026-03-18

Inst OwnersN/A

Inst Owner ChangeN/A

Ins Owners0.11%

Ins Owner ChangeN/A

Market Cap99.62M

Revenue(TTM)28.61M

Net Income(TTM)-13.75M

Analysts40

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	3.48
P/FCF	N/A
P/OCF	N/A
P/B	14.85
P/tB	15.15
EV/EBITDA	N/A

EPS(TTM)-0.07

EYN/A

EPS(NY)-0.14

Fwd EYN/A

FCF(TTM)-0.12

FCFYN/A

OCF(TTM)-0.12

OCFYN/A

SpS0.17

BVpS0.04

TBVpS0.04

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-33.17%
ROE	-204.95%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	34.76%
FCFM	N/A

ROA(3y)-22.13%

ROA(5y)-19.75%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-12.52%

GM growth 5Y37.21%

F-Score5

Asset Turnover0.69

Health

		Industry Rank	Sector Rank
Debt/Equity	0.82
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	16.49%
Cap/Sales	0.71%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.35
Quick Ratio	1.01
Altman-Z	1.13

F-Score5

WACC7.76%

ROIC/WACCN/A

Cap/Depr(3y)26.67%

Cap/Depr(5y)22.95%

Cap/Sales(3y)1.36%

Cap/Sales(5y)1.4%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)81.03%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%73.68%

EPS Next Y9.52%

EPS Next 2Y15.47%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)11.9%

Revenue growth 3Y10.17%

Revenue growth 5Y7.34%

Sales Q2Q%-3.66%

Revenue Next Year-20.83%

Revenue Next 2Y4.08%

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y15.93%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year-14.29%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-806.25%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-895.93%

OCF growth 3YN/A

OCF growth 5YN/A

BALYO SA - PROMESSES / BALYO.PA FAQ

What is the fundamental rating for BALYO stock?

ChartMill assigns a fundamental rating of 2 / 10 to BALYO.PA.

What is the valuation status of BALYO SA - PROMESSES (BALYO.PA) stock?

ChartMill assigns a valuation rating of 0 / 10 to BALYO SA - PROMESSES (BALYO.PA). This can be considered as Overvalued.

What is the profitability of BALYO stock?

BALYO SA - PROMESSES (BALYO.PA) has a profitability rating of 1 / 10.

Can you provide the financial health for BALYO stock?

The financial health rating of BALYO SA - PROMESSES (BALYO.PA) is 2 / 10.

What is the expected EPS growth for BALYO SA - PROMESSES (BALYO.PA) stock?

The Earnings per Share (EPS) of BALYO SA - PROMESSES (BALYO.PA) is expected to grow by 9.52% in the next year.

BALYO SA - PROMESSES (BALYO.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

BALYO SA - PROMESSES / BALYO.PA FAQ

What is the fundamental rating for BALYO stock?

What is the valuation status of BALYO SA - PROMESSES (BALYO.PA) stock?

What is the profitability of BALYO stock?

Can you provide the financial health for BALYO stock?

What is the expected EPS growth for BALYO SA - PROMESSES (BALYO.PA) stock?